Lux vs. wavelength in light treatment of Seasonal Affective Disorder
Lux vs. wavelength in light treatment of Seasonal Affective Disorder
复制标题
DOI:
10.1111/j.1600-0447.2009.01345.x
复制
发表时间:
2009-09-01
影响因子:
6.7
通讯作者:
Lockley, S. W.
中科院分区:
文献类型:
--
作者:
Anderson, J. L.;Glod, C. A.;Lockley, S. W.
Objective:Published dosing guidelines for treatment of Seasonal Affective Disorder (SAD) refer to photopic lux, which is not appropriate for short-wavelength light. Short wavelengths are most potent for many non-visual responses to light. If SAD therapy were similarly mediated, standards utilizing lux risk overestimating necessary dose. We investigated antidepressant responses to light using two light-emitting diode (LED) sources, each emitting substantial short-wavelength light, but < 2500 lux.Method:A randomized, double-blind trial investigated 3-week 45 min/day out-patient treatment with blue-appearing (goLITE((R))) or blue-enriched white-appearing light in 18 moderately-depressed adults (12F, 49.1 +/- 9.5 years). Equivalent numbers of photons within the short-wavelength range were emitted, but the white source emitted twice as many photons overall and seven-fold more lux.Results:Depression ratings (SIGH-ADS; http://www.cet.org) decrease averaged 82% (SD = 17%) from baseline (P < 0.0001) in both white- and blue-light groups. Both sources were well tolerated.Conclusion:Short-wavelength LED light sources may be effective in SAD treatment at fewer lux than traditional fluorescent sources.